Purine metabolism
1975; Wiley; Volume: 18; Issue: S1 Linguagem: Estoniano
10.1002/art.1780180707
ISSN1529-0131
Autores Tópico(s)Cytomegalovirus and herpesvirus research
ResumoArthritis & RheumatismVolume 18, Issue S1 p. 681-686 ArticleFree to Read Purine metabolism J. Edwin Seegmiller MD, J. Edwin Seegmiller MD Professor of Medicine, Department of Medicine, University of California, San Diego, La Jolla, California 92093.Search for more papers by this author J. Edwin Seegmiller MD, J. Edwin Seegmiller MD Professor of Medicine, Department of Medicine, University of California, San Diego, La Jolla, California 92093.Search for more papers by this author First published: November/December 1975 https://doi.org/10.1002/art.1780180707Citations: 15AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Gutman AB: Proceedings of conference on gout and purine metabolism. Arthritis Rheum 8: 589–910, 1965 2. Purine Metabolism in Man: Enzymes and Metabolic Pathways. Edited by O Sperling, A DeVries, JB Wyngaarden. New York, Plenum Press, 1974 3 Seegmiller JE: Diseases of purine and pyrimidine metabolism, Duncan's Diseases of Metabolism. Seventh edition. Edited by PK Bondy, LE Rosenberg. Philadelphia, W. B. Saunders, 1974, pp 655–774 4 Wyngaarden JB, Kelley WN: Gout, The Metabolic Basis of Inherited Disease. Third edition. Edited by JB Stanbury, JB Wyngaarden, DS Fredrickson. New York, McGraw-Hill Book Company, 1972, pp 889–968 5 Seegmiller JE, Rosenbloom FM, Kelley WN: Enzyme defect with a sex-linked human neurological disorder and excessive purine synthesis. Science 155: 1682–1684, 1967 6 Krooth RS, Weinberg H: Properties of galactosemic cells inassociated culture. Biochem Biophys Res Commun 3: 518–524, 1960 7 Sartorelli AC, LePage GA: Metabolic effects of 6-thio-guanine. II. Biosynthesis of nucleic acid purines in vivo and in vitro. Cancer Res 18: 1329–1339, 1958 8 Seegmiller JE, Laster L, Stetten DeW Jr: Incorporation of 4-amino-5-imidazolecarboxamide-4-C13 into uric acid in the normal human. J Biol Chem 216: 653–662, 1955 9 Seegmiller JE, Klinenberg JR, Miller J, et al: Suppression of glycine-15N incorporation into urinary uric acid by adenine-8−13C in normal and gouty subjects. J Clin Invest 47: 1193–1203, 1968 10 Abrams R, Goldfinger JM: Formation of nucleic acid. Arch Biochem 35: 243, 1952 11 Henderson JF: Feedback inhibition of purine biosynthesis in ascites tumor cells. J Biol Chem 237: 2631–2635, 1962 12 McFall E, Magasanik B: Control of purine biosynthesis in cultured mammalian cells. J Biol Chem 235: 2103, 1960 13 Rosenbloom FM, Henderson JF, Caldwell IC, et al: Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthineguanine phosphoribosyltransferase. J Biol Chem 243: 116–1173, 1968 14 Wyngaarden JB, Ashton DM: Regulation of activity of phosphoribosylpyrophosphate amidotransferase by purine ribonucleotides: potential feedback control of purine biosynthesis. J Biol Chem 234: 1492, 1959 15 Seegmiller JE, Laster L, Howell RR: Biochemistry of uric acid and its relation to gout. N Engl J Med 268: 712–716, 764–773, 821–827, 1963 16 Becker MA, Meyer LJ, Wood AW, et al: Gout associated with increased PRPP synthetase activity. Arthritis Rheum 15: 430, 1972 (abstr) 17 Becker MA, Meyer LJ, Wood AW, et al: Purine overproduction in man associated with increased phosphoribosylpyrophosphate synthetase activity. Science 179: 1123–1126, 1973 18 Becker MA, Meyer LJ, Kostel PJ, et al: Increased PPribose-P synthetase activity: A genetic abnormality leading to excessive purine production and gout. Adv Exp Med Biol 41A: 307–315, 1974 19 Wood AW, Seegmiller JE: Properties of 5-phosphoribosyl-1-pyrophosphate glutamine amidotransferase from human lymphoblasts. J Biol Chem 248: 138–143, 1973 20 Wood AW, Becker MA, Seegmiller JE: Purine nucleotide synthesis in lymphoblasts cultured from normal subjects and a patient with the Lesch-Nyhan syndrome. Biochem Genet 9: 261–274, 1973 21 Astrin KH: Purine metabolism in cultured human lymphoid cells. Doctoral thesis. San Diego, University of California, 1973 22 Lesch M, Nyhan WL: A familial disorder of uric acid metabolism and central nervous system function. Am J Med 36: 561–570, 1964 23 Kelley WN, Greene ML, Rosenbloom FM, et al: Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout: a review. Ann Intern Med 70: 155–206, 1969 24 Sperling O, Eilam G, Persky-Brosh S, et al: Accelerated erythrocyte 5-phosphoribosyl-l-pyrophosphate synthesis. A familial abnormality associated with excessive uric acid production and gout. Biochem Med 6: 310–316, 1972 25 Sperling O, Persky-Brosh S, Boer P, et al: Mutant phosphoribosylpyrophosphate synthetase in two gouty siblings with excessive purine production. Adv Exp Med Biol 41A: 299–305, 1974 26 DeVries A, Sperling O: Accelerated erythrocyte 5-phosphoribosyl-l-pyrophosphate synthesis. A familial abnormality associated with excessive uric acid production and gout. Pahlavi Medical Congress. Shiraz, April 1972. Pahlavi Med J 3: 512, 1975 27 Sperling O, Boer P, Persky-Brosh S, et al: Altered kinetic property of erythrocyte phosphoribosylpyrophosphate synthetase in excessive uric acid production. Rev Eur Etud Clin Biol 17: 703–706, 1972 28 Becker MA, Meyer LJ, Seegmiller JE: Gout with purine overproduction due to increased phosphoribosylpyrophosphate synthetase activity. Am J Med 55: 232–242, 1973 29 Becker MA, Kostel PJ, Meyer LJ, et al: Human phosphoribosylpyrophosphate synthetase: increased enzyme specific activity in a family with gout and excessive purine synthesis. Proc Natl Acad Sci USA 70: 2749–2752, 1973 30 Becker MA: Personal communication 31 Becker MA, Seegmiller JE: Genetic aspects of gout. Annu Rev Med 25: 15–28, 1974 32 Henderson JF, Rosenbloom FM, Kelley WN, et al: Variations in purine metabolism of cultured skin fibroblasts from patients with gout. J Clin Invest 47: 1511–1516, 1968 33 Kelley WN, Greene ML, Fox IH, et al: Effects of of orotic acid. Biochim Biophys Acta 215: 512–516, 1970. Man Metabolism 19: 1025–1035, 1970 34 Fox IH, Kelley WN: Pharmacological alterations of intracellular phosphoribosylpyrophosphate (PP-ribose-P) in human tissues. Adv Exp Med Biol 41A: 93–99, 1974 35 Kelley WN, Fox IH, Wyngaarden JB: Regulation of purine biosynthesis in cultured human cells. I. Effects of orotic acid. Biochim Biophys Acta 215: 512–516, 1970 36 Boyle JA, Raivio KO, Becker MA, et al: Effects of nicotinic acid on human fibroblast purine synthesis. Biochim Biophys Acta 269: 179–183, 1972 37 Fox IH, Wyngaarden JB, Kelley WN: Depletion of erythrocyte phosphoribosylpyrophosphate in man. A newly observed effect of allopurinol. N Engl J Med 283: 1177–1182, 1970 38 Gutman AB, Yü TF: Renal function in gout with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. Am J Med 23: 600–622, 1957 39 Seegmiller JE, Grayzel AI, Laster L, et al: Uric acid production in gout. J Clin Invest 40: 1304–1314, 1961 40 Alepa FP, Howell RR, Klinenberg JR, et al: Relationships between glycogen storage disease and tophaceous gout. Am J Med 42: 58–66, 1967 41 Howell RR: Interrelationship of glycogen storage disease and gout. Arthritis Rheum 8: 780–785, 1965 42 Kelley WN, Rosenbloom FM, Seegmiller JE, et al: Excessive production of uric acid in type I glycogen storage disease. J Pediatr 72: 488–496, 1968 43 Jakovcic S, Sorensen LB: Studies of uric acid metabolism in glycogen storage disease associated with gouty arthritis. Arthritis Rheum 10: 129–134, 1967 44 Newcombe DS: Inherited Biochemical Disorders and Uric Acid Metabolism. First edition. Baltimore, University Park Press, 1975 45 Yü TF, Sirota JH, Berger L, et al: Effect of sodium lactate infusion on urate clearance in man. Proc Soc Exp Biol Med 96: 809–813, 1957 46 Goldfinger S, Klinenberg JR, Seegmiller JE: Renal retention of uric acid induced by infusion of Bhydroxybutyrate and acetoacetate. N Engl J Med 272: 351–355, 1965 47 Donnell G: Personal communication 48 Perheentupa J, Raivio KO: Fructose-induced hyperuricemia. Lancet 2: 528–531, 1967 49 Schulman JD, Lustberg TJ, Kennedy JL, et al: A new variant of maple syrup urine disease (branched chain ketoaciduria): clinical and biochemical evaluation. Am J Med 49: 118–124, 1970 Citing Literature Volume18, IssueS1November/December 1975Pages 681-686 ReferencesRelatedInformation
Referência(s)